Table 2.

Primers used in RT-PCR studies.

Oligo name	Sequence
Human EP1 forward	ATGGTGGGCCAGCTTGTC
Human EP1 reverse	GCCACCAACACCAGCATTG
Human EP2 forward	CTGCTGCTGCTTCTCATTGT
Human EP2 reverse	ATGCGGATGAGGTTGAGAAT
Human EP3 forward	GGTCTCCGCTCCTGATAATG
Human EP3 reverse	CTCCGTGTGTGTCTTGCAGT
Human EP4 forward	CGACCTTCTACACGCTGGTATG
Human EP4 reverse	CCGGGCTCACCAACAAAG
Human MSR1 forward	CCGGAAGGCCAGGAAATTCT
Human MSR1 reverse	CCACCGACCAGTCGAACTTT
Human SOCS3 forward	ATTCGGGACCAGCCCCC
Human SOCS3 reverse	AACTTGCTGTGGGTGACCAT
Human MRC1 forward	CGATCCGACCCTTCCTTGAC
Human MRC1 reverse	TGTCTCCGCTTCATGCCATT
Human TGM2 forward	ATAAGTTAGCGCCGCTCTCC
Human TGM2 reverse	ACCAGCTCCTCGGCCAT
Human MSR1 forward	CCGGAAGGCCAGGAAATTCT
Human MSR1 reverse	CCACCGACCAGTCGAACTTT
Human MCP1 forward	CGCTCAGCCAGATGCAATCAA
Human MCP1 reverse	GACACTTGCTGCTGGTGATTC
Human iNOS forward	TCCCGAAGTTCTCAAGGCAC
Human iNOS reverse	TTCTTCACTGTGGGGCTTGC
Human SOCS3 forward	ATTCGGGACCAGCCCCC
Human SOCS3 reverse	AACTTGCTGTGGGTGACCAT
Human HPRT1 forward	CCCTGGCGTCGTGATTAGT
Human HPRT1 reverse	TCTCGAGCAAGACGTTCAGT
Human TBP forward	AGTGACCCAGCATCACTGTTT
Human TBP reverse	GAGCATCTCCAGCACACTCT
Human RPL37A forward	ATTGAAATCAGCCAGCACGC
Human RPL37A reverse	AGGAACCACAGTGCCAGATCC
Human GAPDH forward	AAGGTGAAGGTCGGAGTCAACG
Human GAPDH reverse	CCTTCTCCATGGTGGTGAAGAC
Human CD200R forward	ATGCTCTGCCCTTGGAGAAC
Human CD200R reverse	CTCCGCTTCGGCCACTAA
Human CCL17 forward	AGGGAGCCATTCCCCTTAGA
Human CCL17 reverse	GCACAGTTACAAAAACGATGGC
Human MMP12 forward	AACCAACGCTTGCCAAATCC
Human MMP12 reverse	CCTTCAGCCAGAAGAACCTGT
Human NOX2 forward	TTCACTCTGCGATTCACACCA
Human NOX2 reverse	CGGGCATTCACACACCATTC
Human IL-1b forward	TGAGCTCGCCAGTGAAATGA
Human IL-1b reverse	AGATTCGTAGCTGGATGCCG
Human IL-12B forward	GCCCAGAGCAAGATGTGTCA
Human IL-12B reverse	CACCATTTCTCCAGGGGCAT